ReviewExpert opinion on investigational drugs2023

Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease.

Grace E Vitek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.